Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.13 USD | +4.05% | -3.55% | +36.92% |
Apr. 12 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
Apr. 12 | Sector Update: Health Care | MT |
Financials (USD)
Sales 2024 * | 71.27M | Sales 2025 * | 66.83M | Capitalization | 838M |
---|---|---|---|---|---|
Net income 2024 * | -171M | Net income 2025 * | -221M | EV / Sales 2024 * | 7.6 x |
Net cash position 2024 * | 297M | Net cash position 2025 * | 295M | EV / Sales 2025 * | 8.13 x |
P/E ratio 2024 * |
-4.74
x | P/E ratio 2025 * |
-4.23
x | Employees | 284 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.8% |
1 day | +4.05% | ||
1 week | -3.55% | ||
Current month | -3.88% | ||
1 month | +5.29% | ||
3 months | +76.40% | ||
6 months | +201.28% | ||
Current year | +36.92% |
Managers | Title | Age | Since |
---|---|---|---|
Arthur Sands
CEO | Chief Executive Officer | 62 | 14-09-17 |
Hans van Houte
DFI | Director of Finance/CFO | 58 | 14-12-31 |
Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Judith Reinsdorf
BRD | Director/Board Member | 60 | 21-09-30 |
Paul Silva
BRD | Director/Board Member | 58 | 21-09-30 |
Arthur Sands
CEO | Chief Executive Officer | 62 | 14-09-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.70% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 14.13 | +4.05% | 895,076 |
24-04-22 | 13.58 | -0.07% | 574,496 |
24-04-19 | 13.59 | -5.89% | 1,017,281 |
24-04-18 | 14.44 | +2.56% | 1,489,147 |
24-04-17 | 14.08 | -3.89% | 1,360,922 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.92% | 838M | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+3.26% | 22.19B | |
-16.16% | 21.33B | |
-7.47% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |
- Stock Market
- Equities
- NRIX Stock